A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)

EBioMedicine

Volumn 19, Issue , 2017, Pages 128-138

  Hansel, Trevor T ^a,b,c,d   Tunstall, Tanushree ^c,d   Trujillo Torralbo, Maria Belen ^a,b,c   Shamji, Betty ^e   del Rosario, Ajerico ^a,b,c   Dhariwal, Jaideep ^a,b,c   Kirk, Paul D W ^f   Stumpf, Michael P H ^g   Koopmann, Jens ^a,h   Telcian, Aurica ^a,b   Aniscenko, Julia ^a,b   Gogsadze, Leila ^a,b   Bakhsoliani, Eteri ^a,b   Stanciu, Luminita ^a,b   Bartlett, Nathan ^a,b   Edwards, Michael ^a,b   Walton, Ross ^a,b   Mallia, Patrick ^a,b,c   Hunt, Toby M ⁱ   Hunt, Trevor L ⁱ   Hunt, Duncan G ⁱ   Westwick, John ^e   Edwards, Matthew ^e   Kon, Onn Min ^c,d   Jackson, David J ^a,b,j   Johnston, Sebastian L ^a,b,c   more..

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g Dept of Theoretical Systems Biology at IC ^*  (United Kingdom)

^h MEDIMMUNE LTD   (United Kingdom)

ⁱ Hunt Developments (UK) Limited   (United Kingdom)

^j GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

Absorption of mucosal lining fluid; Asthma; Interferons; Mucosal immunology; Rhinovirus; Type II inflammation

Indexed keywords

BECLOMETASONE; CORTICOSTEROID; CXCL11 CHEMOKINE; EOTAXIN 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 29; INTERLEUKIN 4; INTERLEUKIN 5; CYTOKINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA CONTROL QUESTIONNAIRE; BRONCHITIS; BRONCHOSCOPY; CENTRIFUGATION; CHEMICAL PHENOMENA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; EPITHELIAL LINING FLUID; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INOCULATION; LUNG LAVAGE; MALE; MIDDLE AGED; NASAL LAVAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RECEPTOR UPREGULATION; RESPIRATORY MUCOSA; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; SPIROMETRY; ASTHMA; BRONCHUS; IMMUNOLOGY; NOSE MUCOSA; PICORNAVIRUS INFECTION; RHINOVIRUS; VIROLOGY; VIRUS LOAD; YOUNG ADULT;

ADULT; ASTHMA; BRONCHI; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; VIRAL LOAD; YOUNG ADULT;

EID: 85016488815     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.03.033     Document Type: Article

References (51)

1. Alam, R., Sim, T.C., Hilsmeier, K., Grant, J.A., Development of a new technique for recovery of cytokines from inflammatory sites in situ. J. Immunol. Methods 155 (1992), 25–29.
2. Bardin, P.G., Sanderson, G., Robinson, B.S., Holgate, S.T., Tyrrell, D.A., Experimental rhinovirus infection in volunteers. Eur. Respir. J. 9 (1996), 2250–2255.
3. Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M.A., Kazani, S., Wechsler, M.E., Israel, E., Levy, B.D., Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med., 5, 2013 (174ra126).
4. Bartemes, K.R., Kephart, G.M., Fox, S.J., Kita, H., Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J. Allergy Clin. Immunol. 134 (2014), 671–678 (e674).
5. Beale, J., Jayaraman, A., Jackson, D.J., Macintyre, J.D., Edwards, M.R., Walton, R.P., Zhu, J., Ching, Y.M., Shamji, B., Edwards, M., Westwick, J., Cousins, D.J., Hwang, Y.Y., McKenzie, A., Johnston, S.L., Bartlett, N.W., Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci. Transl. Med., 6, 2014 (256ra134).
6. Brightling, C.E., Chanez, P., Leigh, R., O'Byrne, P.M., Korn, S., She, D., May, R.D., Streicher, K., Ranade, K., Piper, E., Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir. Med. 3 (2015), 692–701.
7. Chawes, B.L., Edwards, M.J., Shamji, B., Walker, C., Nicholson, G.C., Tan, A.J., Folsgaard, N.V., Bonnelykke, K., Bisgaard, H., Hansel, T.T., A novel method for assessing unchallenged levels of mediators in nasal epithelial lining fluid. J. Allergy Clin. Immunol. 125 (2010), 1387–1389.
8. Choy, D.F., Modrek, B., Abbas, A.R., Kummerfeld, S., Clark, H.F., Wu, L.C., Fedorowicz, G., Modrusan, Z., Fahy, J.V., Woodruff, P.G., Arron, J.R., Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J. Immunol. 186 (2011), 1861–1869.
9. Chung, K.F., Targeting the interleukin pathway in the treatment of asthma. Lancet 386 (2015), 1086–1096.
10. Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., Adcock, I.M., Bateman, E.D., Bel, E.H., Bleecker, E.R., Boulet, L.P., Brightling, C., Chanez, P., Dahlen, S.E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jajour, N.N., Mauad, T., Sorkness, R.L., Teague, W.G., International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. 43 (2014), 343–373.
11. Cohen, J., Douma, W.R., ten Hacken, N.H., Vonk, J.M., Oudkerk, M., Postma, D.S., Ciclesonide improves measures of small airway involvement in asthma. Eur. Respir. J. 31 (2008), 1213–1220.
12. Contoli, M., Message, S.D., Laza-Stanca, V., Edwards, M.R., Wark, P.A., Bartlett, N.W., Kebadze, T., Mallia, P., Stanciu, L.A., Parker, H.L., Slater, L., Lewis-Antes, A., Kon, O.M., Holgate, S.T., Davies, D.E., Kotenko, S.V., Papi, A., Johnston, S.L., Role of deficient type III interferon-lambda production in asthma exacerbations. Nat. Med. 12 (2006), 1023–1026.
13. da Silva, J., Hilzendeger, C., Moermans, C., Schleich, F., Henket, M., Kebadze, T., Mallia, P., Edwards, M.R., Johnston, S.L., Louis, R., Raised interferon-beta, type 3 interferon and interferon-stimulated genes - evidence of innate immune activation in neutrophilic asthma. Clin. Exp. Allergy 47 (2017), 313–323.
14. Doberer, D., Trejo Bittar, H.E., Wenzel, S.E., Should lung biopsies be performed in patients with severe asthma?. Eur. Respir. Rev. 24 (2015), 525–539.
15. Edwards, M.R., Regamey, N., Vareille, M., Kieninger, E., Gupta, A., Shoemark, A., Saglani, S., Sykes, A., Macintyre, J., Davies, J., Bossley, C., Bush, A., Johnston, S.L., Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 6 (2013), 797–806.
16. Fahy, J.V., Type 2 inflammation in asthma–present in most, absent in many. Nat. Rev. Immunol. 15 (2015), 57–65.
17. Folsgaard, N.V., Chawes, B.L., Rasmussen, M.A., Bischoff, A.L., Carson, C.G., Stokholm, J., Pedersen, L., Hansel, T.T., Bonnelykke, K., Brix, S., Bisgaard, H., Neonatal cytokine profile in the airway mucosal lining fluid is skewed by maternal atopy. Am. J. Respir. Crit. Care Med. 185 (2012), 275–280.
18. Hambly, N., Nair, P., Monoclonal antibodies for the treatment of refractory asthma. Curr. Opin. Pulm. Med. 20 (2014), 87–94.
19. Hansel, T.T., Johnston, S.L., Openshaw, P.J., Microbes and mucosal immune responses in asthma. Lancet 381 (2013), 861–873.
20. Hentschel, J., Muller, U., Doht, F., Fischer, N., Boer, K., Sonnemann, J., Hipler, C., Hunniger, K., Kurzai, O., Markert, U.R., Mainz, J.G., Influences of nasal lavage collection-, processing- and storage methods on inflammatory markers–evaluation of a method for non-invasive sampling of epithelial lining fluid in cystic fibrosis and other respiratory diseases. J. Immunol. Methods 404 (2014), 41–51.
21. Ishizaka, A., Watanabe, M., Yamashita, T., Ogawa, Y., Koh, H., Hasegawa, N., Nakamura, H., Asano, K., Yamaguchi, K., Kotani, M., Kotani, T., Morisaki, H., Takeda, J., Kobayashi, K., Ogawa, S., New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit. Care Med. 29 (2001), 896–898.
22. Jackson, D.J., Johnston, S.L., The role of viruses in acute exacerbations of asthma. J. Allergy Clin. Immunol. 125 (2010), 1178–1187.
23. Jackson, D.J., Makrinioti, H., Rana, B.M., Shamji, B.W., Trujillo-Torralbo, M.B., Footitt, J., Jerico, D.-R., Telcian, A.G., Nikonova, A., Zhu, J., Aniscenko, J., Gogsadze, L., Bakhsoliani, E., Traub, S., Dhariwal, J., Porter, J., Hunt, D., Hunt, T., Hunt, T., Stanciu, L.A., Khaitov, M., Bartlett, N.W., Edwards, M.R., Kon, O.M., Mallia, P., Papadopoulos, N.G., Akdis, C.A., Westwick, J., Edwards, M.J., Cousins, D.J., Walton, R.P., Johnston, S.L., IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 190 (2014), 1373–1382.
24. Jackson, D.J., Glanville, N., Trujillo-Torralbo, M.B., Shamji, B.W., Del-Rosario, J., Mallia, P., Edwards, M.J., Walton, R.P., Edwards, M.R., Johnston, S.L., Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations. Clin. Infect. Dis. 60 (2015), 1528–1531.
25. Jayaraman, A., Jackson, D.J., Message, S.D., Pearson, R.M., Aniscenko, J., Caramori, G., Mallia, P., Papi, A., Shamji, B., Edwards, M., Westwick, J., Hansel, T., Stanciu, L.A., Johnston, S.L., Bartlett, N.W., IL-15 complexes induce NK- and T-cell responses independent of type I IFN signaling during rhinovirus infection. Mucosal Immunol. 7 (2014), 1151–1164.
26. Jochems, S.P., Piddock, K., Rylance, J., Adler, H., Carniel, B.F., Collins, A., Gritzfeld, J.F., Hancock, C., Hill, H., Reine, J., Seddon, A., Solorzano, C., Sunny, S., Trimble, A., Wright, A.D., Zaidi, S., Gordon, S.B., Ferreira, D.M., Novel analysis of immune cells from nasal microbiopsy demonstrates reliable, reproducible data for immune populations, and superior cytokine detection compared to nasal wash. PLoS One, 12, 2017, e0169805.
27. Koltsida, O., Hausding, M., Stavropoulos, A., Koch, S., Tzelepis, G., Ubel, C., Kotenko, S.V., Sideras, P., Lehr, H.A., Tepe, M., Klucher, K.M., Doyle, S.E., Neurath, M.F., Finotto, S., Andreakos, E., IL-28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol. Med. 3 (2011), 348–361.
28. Laza-Stanca, V., Message, S.D., Edwards, M.R., Parker, H.L., Zdrenghea, M.T., Kebadze, T., Kon, O.M., Mallia, P., Stanciu, L.A., Johnston, S.L., The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog., 7, 2011, e1002114.
29. Leaker, B.R., Malkov, V.A., Mogg, R., Ruddy, M.K., Nicholson, G.C., Tan, A.J., Tribouley, C., Chen, G., De Lepeleire, I., Calder, N.A., Chung, H., Lavender, P., Carayannopoulos, L.N., Hansel, T.T., The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1beta), and complement. Mucosal Immunol. 10 (2017), 408–420.
30. Lewis, T.C., Henderson, T.A., Carpenter, A.R., Ramirez, I.A., McHenry, C.L., Goldsmith, A.M., Ren, X., Mentz, G.B., Mukherjee, B., Robins, T.G., Joiner, T.A., Mohammad, L.S., Nguyen, E.R., Burns, M.A., Burke, D.T., Hershenson, M.B., Nasal cytokine responses to natural colds in asthmatic children. Clin. Exp. Allergy 42 (2012), 1734–1744.
31. Lu, F.X., Esch, R.E., Novel nasal secretion collection method for the analysis of allergen specific antibodies and inflammatory biomarkers. J. Immunol. Methods 356 (2010), 6–17.
32. McGrath, K.W., Icitovic, N., Boushey, H.A., Lazarus, S.C., Sutherland, E.R., Chinchilli, V.M., Fahy, J.V., A large subgroup of mild-to-moderate asthma is persistently non-eosinophilic. Am. J. Respir. Crit. Care Med. 185 (2012), 612–619.
33. Message, S.D., Laza-Stanca, V., Mallia, P., Parker, H.L., Zhu, J., Kebadze, T., Contoli, M., Sanderson, G., Kon, O.M., Papi, A., Jeffery, P.K., Stanciu, L.A., Johnston, S.L., Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 13562–13567.
34. Miller, E.K., Hernandez, J.Z., Wimmenauer, V., Shepherd, B.E., Hijano, D., Libster, R., Serra, M.E., Bhat, N., Batalle, J.P., Mohamed, Y., Reynaldi, A., Rodriguez, A., Otello, M., Pisapia, N., Bugna, J., Bellabarba, M., Kraft, D., Coviello, S., Ferolla, F.M., Chen, A., London, S.J., Siberry, G.K., Williams, J.V., Polack, F.P., A mechanistic role for type III IFN-lambda1 in asthma exacerbations mediated by human rhinoviruses. Am. J. Respir. Crit. Care Med. 185 (2012), 508–516.
35. Molofsky, A.B., Van Gool, F., Liang, H.E., Van Dyken, S.J., Nussbaum, J.C., Lee, J., Bluestone, J.A., Locksley, R.M., Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 43 (2015), 161–174.
36. Moore, W.C., Hastie, A.T., Li, X.N., Li, H.S., Busse, W.W., Jarjour, N.N., Wenzel, S.E., Peters, S.P., Meyers, D.A., Bleecker, E.R., Severe NHLBI. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J. Allergy Clin. Immunol., 133, 2014, 1557.
37. Nicholson, G.C., Kariyawasam, H.H., Tan, A.J., Hohlfeld, J.M., Quinn, D., Walker, C., Rodman, D., Westwick, J., Jurcevic, S., Kon, O.M., Barnes, P.J., Krug, N., Hansel, T.T., The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge. J. Allergy Clin. Immunol. 128 (2011), 800–807.
38. Opgen-Rhein, R., Strimmer, K., Inferring gene dependency networks from genomic longitudinal data: a functional data approach. REVSTAT Stat. J., 2006, 53–65.
39. Patel, D.A., You, Y., Huang, G., Byers, D.E., Kim, H.J., Agapov, E., Moore, M.L., Peebles, R.S. Jr., Castro, M., Sumino, K., Shifren, A., Brody, S.L., Holtzman, M.J., Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J. Allergy Clin. Immunol. 134 (2014), 1402–1412 (e1407).
40. Poole, A., Urbanek, C., Eng, C., Schageman, J., Jacobson, S., O'Connor, B.P., Galanter, J.M., Gignoux, C.R., Roth, L.A., Kumar, R., Lutz, S., Liu, A.H., Fingerlin, T.E., Setterquist, R.A., Burchard, E.G., Rodriguez-Santana, J., Seibold, M.A., Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J. Allergy Clin. Immunol. 133 (2014), 670–678 (e612).
41. Raundhal, M., Morse, C., Khare, A., Oriss, T.B., Milosevic, J., Trudeau, J., Huff, R., Pilewski, J., Holguin, F., Kolls, J., Wenzel, S., Ray, P., Ray, A., High IFN-gamma and low SLPI mark severe asthma in mice and humans. J. Clin. Invest. 125 (2015), 3037–3050.
42. Riechelmann, H., Deutschle, T., Friemel, E., Gross, H.J., Bachem, M., Biological markers in nasal secretions. Eur. Respir. J. 21 (2003), 600–605.
43. Scadding, G.W., Calderon, M.A., Bellido, V., Koed, G.K., Nielsen, N.C., Lund, K., Togias, A., Phippard, D., Turka, L.A., Hansel, T.T., Durham, S.R., Wurtzen, P.A., Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes. J. Immunol. Methods 384 (2012), 25–32.
44. Scadding, G.W., Eifan, A., Penagos, M., Dumitru, A., Switzer, A., McMahon, O., Phippard, D., Togias, A., Durham, S.R., Shamji, M.H., Local and systemic effects of cat allergen nasal provocation. Clin. Exp. Allergy 45 (2015), 613–623.
45. Sykes, A., Edwards, M.R., Macintyre, J., del Rosario, A., Bakhsoliani, E., Trujillo-Torralbo, M.B., Kon, O.M., Mallia, P., McHale, M., Johnston, S.L., Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J. Allergy Clin. Immunol. 129 (2012), 1506–1514.
46. Sykes, A., Edwards, M.R., Macintyre, J., Del Rosario, A., Gielen, V., Haas, J., Kon, O.M., McHale, M., Johnston, S.L., TLR3, TLR4 and TLRs7-9 induced interferons are not impaired in airway and blood cells in well controlled asthma. PLoS One, 8, 2013, e65921.
47. Sykes, A., Macintyre, J., Edwards, M.R., del Rosario, A., Haas, J., Gielen, V., Kon, O.M., McHale, M., Johnston, S.L., Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69 (2014), 240–246.
48. Walker, J.A., Barlow, J.L., McKenzie, A.N., Innate lymphoid cells–how did we miss them?. Nat. Rev. Immunol. 13 (2013), 75–87.
49. Wark, P.A.B., Johnston, S.L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S.T., Davies, D.E., Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201 (2005), 937–947.
50. Wenzel, S.E., Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18 (2012), 716–725.
51. Yu, S., Kim, H.Y., Chang, Y.J., DeKruyff, R.H., Umetsu, D.T., Innate lymphoid cells and asthma. J. Allergy Clin. Immunol. 133 (2014), 943–950 (quiz 951).